Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
Slightly above 67% of Apyx Medical's investor base is looking to short. The analysis of overall sentiment of trading Apyx Medical stock suggests that many investors are alarmed at this time. Apyx Medical's investing sentiment can be driven by a variety of factors including economic data, Apyx Medical's earnings reports, geopolitical events, and overall market trends.
Apyx |
CLEARWATER, Fla., August 08, 2024--Apyx Medical Corporation , the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion, today announced the publication of a peer-reviewed article in the journal, Plastic and Reconstructive SurgeryGlobal Open, featuring the results of study which compared the use of Renuvions Helium Plasma Technology to InModes Bipolar RF System following lip
Read at finance.yahoo.com
 |
Apyx Medical Fundamental Analysis
We analyze Apyx Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apyx Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Apyx Medical is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Apyx Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apyx Medical stock to make a market-neutral strategy. Peer analysis of Apyx Medical could also be used in its relative valuation, which is a method of valuing Apyx Medical by comparing valuation metrics with similar companies.
Peers
Apyx Medical Related Equities
| OFIX | Orthofix Medical | 2.73 | ||||
| SRDX | SurModics | 1.65 | ||||
| ANIK | Anika Therapeutics | 1.47 | ||||
| KIDS | Orthopediatrics Corp | 1.06 | ||||
| ELMD | Electromed | 0.28 | ||||
| LIVN | LivaNova PLC | 0.42 | ||||
| SGHT | Sight Sciences | 1.55 | ||||
| LUNG | Pulmonx Corp | 1.71 | ||||
| AVNS | Avanos Medical | 2.45 | ||||
| NPCE | Neuropace | 7.23 |
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.